These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9627709)

  • 1. Multistage carcinogenesis in the skin.
    Yuspa SH; Dlugosz AA; Denning MF; Glick AB
    J Investig Dermatol Symp Proc; 1996 Apr; 1(2):147-50. PubMed ID: 9627709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
    Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
    Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
    Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of oncogenes and tumor suppressor genes in multistage carcinogenesis.
    Yuspa SH; Długosz AA; Cheng CK; Denning MF; Tennenbaum T; Glick AB; Weinberg WC
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):90S-95S. PubMed ID: 7963691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.
    Glick AB; Lee MM; Darwiche N; Kulkarni AB; Karlsson S; Yuspa SH
    Genes Dev; 1994 Oct; 8(20):2429-40. PubMed ID: 7958907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
    Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the TGF-beta coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis.
    Quintanilla M; Ramirez JR; Pérez-Gómez E; Romero D; Velasco B; Letarte M; López-Novoa JM; Bernabéu C
    Oncogene; 2003 Sep; 22(38):5976-85. PubMed ID: 12955076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis.
    Hennings H; Glick AB; Greenhalgh DA; Morgan DL; Strickland JE; Tennenbaum T; Yuspa SH
    Proc Soc Exp Biol Med; 1993 Jan; 202(1):1-8. PubMed ID: 8424089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis.
    Yuspa SH
    J Dermatol Sci; 1998 May; 17(1):1-7. PubMed ID: 9651822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta 1 and skin carcinogenesis: antiproliferative effect in vitro and TGF-beta 1 mRNA expression during epidermal hyperproliferation and multistage tumorigenesis.
    Krieg P; Schnapke R; Fürstenberger G; Vogt I; Marks F
    Mol Carcinog; 1991; 4(2):129-37. PubMed ID: 1710462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor ligands regulate keratin 8 expression in keratinocytes, and transforming growth factor alpha mediates the induction of keratin 8 by the v-rasHa oncogene.
    Cheng C; Tennenbaum T; Dempsey PJ; Coffey RJ; Yuspa SH; Dlugosz AA
    Cell Growth Differ; 1993 Apr; 4(4):317-27. PubMed ID: 7684248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression.
    Darwiche N; Scita G; Jones C; Rutberg S; Greenwald E; Tennenbaum T; Collins SJ; De Luca LM; Yuspa SH
    Cancer Res; 1996 Nov; 56(21):4942-9. PubMed ID: 8895748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
    Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
    Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant transforming growth factor beta 1 RNA and protein localization during chemical carcinogenesis of the skin.
    Fowlis DJ; Flanders KC; Duffie E; Balmain A; Akhurst RJ
    Cell Growth Differ; 1992 Feb; 3(2):81-91. PubMed ID: 1504019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
    Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
    Vijayachandra K; Lee J; Glick AB
    Cancer Res; 2003 Jul; 63(13):3447-52. PubMed ID: 12839923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
    DiGiovanni J; Rho O; Xian W; Beltràn L
    Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of malignant conversion in skin carcinogenesis.
    Yuspa SH; Greenhalgh DA
    Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the regulation of intracellular calcium in normal and neoplastic keratinocytes are not caused by ras gene mutations.
    Kruszewski FH; Hennings H; Tucker RW; Yuspa SH
    Cancer Res; 1991 Aug; 51(16):4206-12. PubMed ID: 1907882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.